Drug Overdose Clinical Trial
Official title:
Developing a Prescription Opioid Overdose Prevention Intervention in Addictions Treatment
Use of opioid medications for treatment of pain has increased greatly in the U.S., with the
average quantity of prescribed opioids increasing 700% in a decade, from ~100 morphine
milligram equivalents (MME) per person to ~700 MME per person from 1997 to 2007. There have
been concurrent increases in opioid-related adverse outcomes, such as extramedical use,
opioid use disorders, and overdose. As a result, there were more unintentional poisoning
deaths than deaths due to motor vehicle crashes among adults in 2010 (32,723 vs. 32,640).
Additionally, the number of Americans seeking treatment for opioid use disorders has
increased; in SAMHSA's Treatment Episode Data Set, prescription opioids were the primary
substance of abuse for 142,782 individuals in 2009, compared to 22,637 in 1999, a 530%
increase.
The specific aims of this project are to: (1) Refine a motivational enhancement prevention
intervention for prescription opioid overdose risk reduction and improved witnessed overdose
response for at-risk patients in addictions treatment; (2) Conduct a pilot randomized
controlled trial comparing the prescription opioid overdose prevention intervention to a
supportive educational control condition for patients in addictions treatment in order to:
(a) obtain information about the feasibility of randomized controlled procedures; and (b)
determine the distribution and variability of the primary (overdose risk behaviors) and
mediating/secondary (witnessed overdose response, self-efficacy to reduce overdose risk,
knowledge of overdose risk factors and symptom recognition) outcomes; and (3) Determine the
distribution and variability in changes in HIV risk behaviors (e.g., reductions in injection
of prescription opioids) over follow-up.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04070521 -
EEG Monitoring in the Emergency Department
|
||
| Completed |
NCT04372238 -
The Rhode Island Prescription and Illicit Drug Study
|
N/A | |
| Withdrawn |
NCT04391192 -
Virtual Overdose Response
|
N/A | |
| Completed |
NCT02924454 -
Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.
|
Phase 4 | |
| Completed |
NCT02282306 -
Phone Interview to Prevent Recurring Opioid Overdoses
|
N/A | |
| Not yet recruiting |
NCT01912573 -
Nasal Naloxone for Narcotic Overdose
|
Phase 4 | |
| Completed |
NCT04091659 -
Use of Virtual Reality for Overdose Management Educational Trainings
|
N/A | |
| Recruiting |
NCT05517668 -
Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose
|
Phase 2 | |
| Completed |
NCT02572089 -
Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers
|
Phase 1 | |
| Active, not recruiting |
NCT05096429 -
Preventing Overdose Using Information and Data From the Environment
|
N/A | |
| Recruiting |
NCT03845699 -
Development of an Algorithm That Predicts Hypoventilation Due to an Opioid Overdose
|
||
| Completed |
NCT03840018 -
Effectiveness of a Postal Intervention to Improve the Use of PPI
|
N/A | |
| Completed |
NCT03087149 -
Monitored vs Standard Supplementation of Vitamin D in Preterm Infants
|
N/A | |
| Recruiting |
NCT05657106 -
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
|
N/A | |
| Completed |
NCT02598856 -
Bioavailability of Nasal Naloxone and Injected Naloxone Compared
|
Phase 1 | |
| Completed |
NCT02158117 -
Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use
|
Phase 1 | |
| Recruiting |
NCT05146336 -
CytOSorb TreatMent Of Critically Ill PatientS Registry
|
||
| Not yet recruiting |
NCT02733822 -
Buccal Versus Injectable Naloxone: a Phase I Healthy Volunteer Study
|
Phase 1 | |
| Not yet recruiting |
NCT06327061 -
Social Network Overdose Prevention and Education Intervention
|
N/A | |
| Active, not recruiting |
NCT05308303 -
AI to Improve Data From Danish Cardiac Arrest Registry
|